Amgen’s Amgevita, biosimilar of AbbVie’s Humira (adalimumab), has been approved by the European Commission
Reference Biologic – Humira (adalimumab) of AbbVie Biosimilar – Amgevita (adalimumab) of Amgen European Commission (EC) has granted marketing authorization for AMGEVITA™... Read More